Our Editorial team will be focused on delivering rapid, independent coverage of the most important advances in oncology. From real-time updates to in-depth analysis of practice-changing clinical trials with global thought leaders, our mission is to provide healthcare professionals with high-quality, accessible IME. Stay tuned for the latest updates across our VJOncology disease education channels.

Our ability to deliver this innovative and impactful educational content is made possible thanks to financial support from our industry partners. Supporting VJOncology’s activities provides pharmaceutical and biotech companies with a unique opportunity to support the creation of trusted IME. Recognized by oncology professionals for its integrity and depth, our platform provides a respected source for sharing clinical insights, enabling meaningful scientific dialogue, and amplifying important congress data to a global audience beyond the meeting itself.

If you would like to be part of this mission to deliver high-quality IME, or to connect with us in person at ESMO, get in touch to by emailing [email protected] .

Written by Henry Shippey, Partnerships Manager at Magdalen Medical Publishing